Collectively, these findings uncover a mechanism linking ACLY to copper homeostasis in BAT and highlight SST as a promising repurposed candidate for correcting obesity and BAT dysfunction-associated metabolic disorders. The gene discussed is ACLY; the disease is obesity due to melanocortin 4 receptor deficiency.